Usage Comparisons You should never take both Rybelsus and Ozempic together, and your doctor should never prescribe both at the same time
George Tirzepatide acts on both GIP and GLP-1 receptors to support appetite control and weight loss
doi:10.1097/AUD.0000000000001273
Moving forward, the most realistic near-term translational path lies in combining relatively simple, biocompatible bone-targeted nanocarriers (such as alendronate-functionalized liposomal or polymeric systems) to specifically co-deliver immunogenic cell death (ICD)-inducing standard chemotherapeutics alongside established immune checkpoint inhibitors (e.g., anti-PD-1/PD-L1) or myeloid cell modulators
It does not replace emergency care, diagnosis, or treatment from a physician
Quick Answer: GLP-1 receptor agonists may influence substance use behaviors through effects on brain reward circuits, but they currently have no FDA approval for treating substance use disorders